NHS National Framework for Transition products (Nilotinib and Ticagrelor)

NHS ENGLAND

There is 1 contract in this contracting process.

Summary of the contracting process

NHS England is currently in the planning stage of a public procurement for the NHS National Framework for Transition products, specifically Nilotinib and Ticagrelor. The framework agreement is scheduled to commence on 1st September 2025 and will initially run until 31st January 2027, with potential extensions up to 2029. This procurement falls under the pharmaceutical products category and will be executed across the United Kingdom. Key deadlines include an upcoming supplier engagement date on 25th April 2025, followed by the publication of further notice on 30th April 2025. The contracting process is aimed at central government public authority with NHS England based in Leeds, United Kingdom, facilitating the process.

This tender represents a significant opportunity for businesses operating in the pharmaceutical sector, especially SMEs, due to the framework agreement structure allowing multiple call-offs and extensions. By participating, suppliers can establish a long-term business relationship with NHS England, leading to consistent revenue flow over several years. Companies that provide transition products like Nilotinib and Ticagrelor, and those with capabilities in pharmaceutical distribution within the UK, will find this tender particularly advantageous for business expansion and growth.

This is an AI-generated summary 🚀

How useful is this summary?

Planning

NHS National Framework for Transition products (Nilotinib and Ticagrelor)

NHS ENGLAND

Contract Timeline

Publication Date

9th April 2025 11:44:39 AM

Planning Deadline

25th April 2025 22:59:59 PM Expired
Contract Summary

Project title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025 Offer reference number: CM/TNS/24/5721 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5721/01 - Nilotinib and Ticagrelor Lot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months) Lot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
Contract Details

Open Contracting ID

ocds-h6vhtk-04ff90

Publication Source

Find a Tender Service

Procurement Stage

Planning

Procurement Method

N/A

Procurement Method Details

N/A

Procurement Category

Goods

Tender Suitability

Framework / DPS

Framework
Contract Classification

CPV Code(s)

CPV Division(s)
Awarding Authority

NHS ENGLAND

Buyer Name

Buyer Email

katie.noonan@nhs.net

Buyer Phone

Buyer Address

7-8 Wellington Place

Leeds

LS1 4AP

United Kingdom

View contract on Find a Tender Service

NHS National Framework for Transition products (Nilotinib and Ticagrelor)

NHS ENGLAND

Contract Timeline

Contract Summary

Contract Details

Contract Classification

Awarding Authority